Advertisement

Ads Placeholder
Loading...

Kodiak Sciences Inc.

KODNASDAQ
Healthcare
Biotechnology
$40.63
$-2.18(-5.09%)
U.S. Market opens in 26h 37m

Kodiak Sciences Inc. (KOD) Stock Overview

Explore Kodiak Sciences Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2.2B
P/E Ratio-9.40
EPS (TTM)$-4.32
ROE-2.55%
Fundamental Analysis

AI Price Forecasts

1 Month$23.59
3 Months$29.01
1 Year Target$35.00

KOD Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Kodiak Sciences Inc. (KOD) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 68.19, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $35.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -9.40 and a market capitalization of 2.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-5.09%
5-Day Change
-3.01%
1-Month Change
53.67%
3-Month Change
56.15%
6-Month Change
169.79%
Year-to-Date (YTD) Change
56.15%
1-Year Change
1592.92%
3-Year Change
646.88%
5-Year Change
75.81%
All-Time (Max) Change
1901.48%

Contact Information

650 281 0850
1200 Page Mill Road, Palo Alto, CA, 94304

Company Facts

1,090 Employees
IPO DateOct 4, 2018
CountryUS
Actively Trading

Frequently Asked Questions